Vergleich

UK-78282 hydrochloride Europäischer Partner

ArtNr ALO-U-100-50mg
Hersteller Alomone
CAS-Nr. 136647-02-4
Menge 50 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Kategorie
Typ Small Molecules
Format Lyophilized
Specific against other
Purity >95%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
KV1.3, KV1.4 K+ channels
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C.
Molecular Weight
466, 1
Manufacturer - Format
Lyophilized Powder
Short description
A Blocker of KV1.3 and KV1.4 K+ Channels
Description
A Blocker of KV1.3 and KV1.4 K+ Channels
Reconstitution
200 mM in DMSO. Centrifuge all product preparations before use (10000 x g for 1 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
200 nM - 200 µM.
Activity
UK-78282 hydrochloride blocks KV1.3 and KV1.4 in T lymphocytes1.
Solubility
200 mM in DMSO. Centrifuge all product preparations before use (10000 x g for 1 min).
Bioassay tested
Yes
Chemical Name
4-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]piperidine; hydrochloride.
Scientific Background
UK-78282 hydrochloride is a novel piperidine blocker of the T lymphocyte voltage-gated K+ channel, KV1.3 and KV1.4 with IC50 values of 0.28 and 0.17 μM respectively. UK-78282 suppresses T lymphocyte mitogenesis and leads to membrane depolarization. UK-78282 also blocks KV1.4 expressed in heart and brain. UK-78282 preferentially blocks the C-type inactivated state of the KV1.3 channel. KV1.3 mutants containing hydrophobic residues that might prefer to be buried, transition slowly into the C-type inactivated conformation and are insensitive to block by UK-78282, possibly because of the inability of the drug to bind the channel. UK-78282 hydrochloride serves as an experimental tool to probe the conformational changes in KV1.3 leading to C-type inactivation and to further define the critical physiological role of KV1.3 in T lymphocyte activation1.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 50 mg
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 04.12.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen